These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20477906)

  • 21. Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation.
    Omote Y; Deguchi K; Kurata T; Yamashita T; Sato K; Hishikawa N; Abe K
    Curr Neurovasc Res; 2015; 12(1):91-7. PubMed ID: 25557372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
    Clemenz M; Frost N; Schupp M; Caron S; Foryst-Ludwig A; Böhm C; Hartge M; Gust R; Staels B; Unger T; Kintscher U
    Diabetes; 2008 May; 57(5):1405-13. PubMed ID: 18184928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats.
    Kishi T; Hirooka Y; Sunagawa K
    J Cardiol; 2012 Dec; 60(6):489-94. PubMed ID: 22948091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
    Yamamoto K; Ohishi M; Ho C; Kurtz TW; Rakugi H
    Hypertension; 2009 Dec; 54(6):1353-9. PubMed ID: 19822796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice.
    Rong X; Li Y; Ebihara K; Zhao M; Naowaboot J; Kusakabe T; Kuwahara K; Murray M; Nakao K
    Diabetologia; 2010 Aug; 53(8):1727-31. PubMed ID: 20390403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrangea serrata Tea Enhances Running Endurance and Skeletal Muscle Mass.
    Jang YJ; Ahn J; Son HJ; Jung CH; Ahn J; Ha TY
    Mol Nutr Food Res; 2019 Sep; 63(17):e1801149. PubMed ID: 31120170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion.
    Washida K; Ihara M; Nishio K; Fujita Y; Maki T; Yamada M; Takahashi J; Wu X; Kihara T; Ito H; Tomimoto H; Takahashi R
    Stroke; 2010 Aug; 41(8):1798-806. PubMed ID: 20595663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques.
    Noda A; Fushiki H; Murakami Y; Sasaki H; Miyoshi S; Kakuta H; Nishimura S
    Nucl Med Biol; 2012 Nov; 39(8):1232-5. PubMed ID: 22890047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
    Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
    J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
    Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telmisartan as metabolic modulator: a new perspective in sports doping?
    Sanchis-Gomar F; Lippi G
    J Strength Cond Res; 2012 Mar; 26(3):608-10. PubMed ID: 22130396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardized Kaempferia parviflora Extract Enhances Exercise Performance Through Activation of Mitochondrial Biogenesis.
    Kim MB; Kim T; Kim C; Hwang JK
    J Med Food; 2018 Jan; 21(1):30-38. PubMed ID: 29125913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan.
    Penna-de-Carvalho A; Graus-Nunes F; Rabelo-Andrade J; Mandarim-de-Lacerda CA; Souza-Mello V
    Exp Physiol; 2014 Dec; 99(12):1663-78. PubMed ID: 25326526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.
    Xu C; Fang D; Chen X; Xinyue L; Nie Y; Xie Y; Ma Y; Deng S; Zhang Z; Song X
    Eur J Pharmacol; 2015 Sep; 762():364-71. PubMed ID: 26057693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-receptor blocking agents and the peroxisome proliferator-activated receptor-gamma system.
    Tuck ML
    Curr Hypertens Rep; 2005 Aug; 7(4):240-3. PubMed ID: 16061040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats.
    Younis F; Oron Y; Limor R; Stern N; Rosenthal T
    Metabolism; 2012 Feb; 61(2):164-74. PubMed ID: 21820685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
    Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
    Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats.
    Su X; Yu R; Yang X; Zhou G; Wang Y; Li L; Li D
    Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):671-9. PubMed ID: 25867712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders.
    Yamagishi S; Nakamura K; Matsui T
    Curr Mol Med; 2007 Aug; 7(5):463-9. PubMed ID: 17691961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
    Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
    Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.